The study compared two enteral nutrition formulas, one with a higher protein content and one with the standard amount, to determine whether increased protein would help patients recover more quickly or survive longer. While the study did not show a benefit of higher protein dose in critical illness, the findings are meaningful for practice, providing clear evidence to guide safer protein delivery in critical care. 

Equally importantly, the trial has set the stage for future research. It has raised new questions about whether higher protein might help certain patient groups, or whether it may be best introduced later, during the recovery phase of critical illness. These insights are shaping the next generation of studies in ICU nutrition.